BRIEF published on 11/05/2024 at 19:25, 17 days 13 hours ago CannaPharmaRx Advances with New Cannabis Shipment to Israel Revenue Growth International Expansion CannapharmaRx Cannabis Shipment Israel Market
PRESS RELEASE published on 11/05/2024 at 19:20, 17 days 13 hours ago CannapharmaRx to Complete Additional Shipment in November CannaPharmaRX, Inc. reports continued progress at its cannabis facility in Cremona, Alberta. Recent shipments to Israel show growth potential. Expansion plans in Europe and globally Global Expansion Revenue Growth CannapharmaRx Cannabis Production Shipments To Israel
BRIEF published on 08/15/2024 at 19:00, 3 months 7 days ago CannaPharmaRx Receives Multiple Purchase Orders and Begins Delivery of Product International Expansion Medical Cannabis CannapharmaRx Cannabis Production Purchase Orders
PRESS RELEASE published on 08/15/2024 at 18:55, 3 months 7 days ago CannaPharmaRx Receives Multiple Purchase Orders and Begins Delivery of Product CannaPharmaRx, Inc. receives 600KG cannabis orders from Cantek Holdings, further solidifying its position in the cannabis market internationally. Continues high-quality production at Cremona facility International Markets CannapharmaRx Cantek Holdings Cannabis Orders Cremona Facility
BRIEF published on 06/28/2024 at 09:05, 4 months 25 days ago CannaPharmaRx Reports Q1 2024 Financial Performance Financial Results Revenue Operating Expenses Licenses Strategic Agreements
PRESS RELEASE published on 06/28/2024 at 09:00, 4 months 25 days ago Q1 2024 Financial Results CannaPharmaRx reports Q1 2024 financial results with revenue commencing. The company anticipates accelerated growth, international expansion, and strategic partnerships Financial Results Revenue Growth Q1 2024 CannapharmaRx
BRIEF published on 05/20/2024 at 19:50, 6 months 2 days ago CannaPharmaRx to Host Investor Conference Call on May 21, 2024 Investor Conference Call Financial Update Cannabis Production Dean Medwid
PRESS RELEASE published on 05/20/2024 at 19:45, 6 months 2 days ago CORRECTION FROM SOURCE: CannaPharmaRx to Host Investor Conference Call CannaPharmaRx, Inc. (OTC PINK:CPMD) will host an investor conference call on May 21, 2024, at 1PM Eastern time to provide updates on financials, products, distribution, and expansion Investor Conference Call Financial Update CannapharmaRx Cannabis Production CPMD
BRIEF published on 05/20/2024 at 18:35, 6 months 2 days ago CannaPharmaRx to Host Investor Conference Call Investor Conference Financial Update CannapharmaRx Cannabis Production Dean Medwid
PRESS RELEASE published on 05/20/2024 at 18:30, 6 months 2 days ago CannaPharmaRx to Host Investor Conference Call CannaPharmaRx, Inc. to hold investor conference call on May 21, 2024, providing updates on financials, products, orders, and forecasts. Visit www.cannapharmarx.com for details Investor Conference Call Financial Update CannapharmaRx Cannabis Production Forecasted Revenues
Published on 11/22/2024 at 23:55, 9 hours 24 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 9 hours 49 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 10 hours 14 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 10 hours 49 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 15 hours 4 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 15 hours 25 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 16 hours 23 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 17 hours 19 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 2 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 13 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 15 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 15 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
